Central Pharma

Central Pharma

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Central Pharma is a private, revenue-generating contract development and manufacturing organization (CDMO) and service provider headquartered in Nottingham, UK. The company provides critical outsourced services including contract packing, cold chain storage, regulatory consultancy, and supply chain logistics primarily for the pharmaceutical, medical device, and cell & gene therapy sectors. Its multi-site operations, global accreditations, and focus on GxP compliance position it as a flexible partner for healthcare companies seeking scalable, audit-ready support. Central Pharma's growth is driven by strategic partnerships and a focus on high-growth areas like cell and gene therapies.

Drug Delivery

Technology Platform

Integrated service platform for regulated healthcare products, encompassing advanced contract packing systems, serialization/traceability software, specialist cold-chain storage & logistics, and regulatory/quality management systems.

Opportunities

The rapid growth of cell & gene therapies and biologics creates strong demand for specialized cold-chain storage and handling services.
Increasing regulatory complexity and the trend toward virtual biotech models drive outsourcing, expanding the client base for compliant contract service providers.

Risk Factors

Revenue is tied to client pipelines and biotech funding cycles, creating potential volatility.
The core business faces significant regulatory risk, where any compliance failure could damage reputation and licenses.
The market is highly competitive with large global CDMOs and niche specialists.

Competitive Landscape

Central Pharma competes in the fragmented contract packaging and storage market against large global CDMOs (e.g., Catalent, Lonza), specialized logistics firms, and regional service providers. Its differentiation lies in a strong compliance focus, multi-site flexibility, and a targeted niche in cell & gene therapy support through partnerships.